Widespread expression of inducible NOS and citrulline in lupus nephritis tissues

Inflammation Research

Volumn 58, Issue 2, 2009, Pages 61-66

  Bollain Y Goytia, J J ^a,b   Ramirez Sandoval R ^a,b   Daza, L ^c   Esparza, E ^a,b   Barbosa, O ^a,b   Ramirez, D ^a,b   Pacheco Tovar, G ^a,b   Avalos Diaz, E ^a,b   Rodriguez Padilla C ^d   Herrera Esparza, R ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE ZACATECAS   (Mexico)

^b Instituto Mexicano del Seguro Social ^*  (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Citrulline; Free radicals and tissue damage; Inflammatory mediators; iNOs; Lupus nephritis

Indexed keywords

CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; RNA;

ADOLESCENT; ADULT; ARTICLE; ENZYME ACTIVITY; FEMALE; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 59049107990     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-7215-1     Document Type: Article

References (21)

1. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide sythesis by localizing constitutive NO synthases in mammalian kidney. Am. J.Physiol 1995; 268: F885-F898.
2. Förstermann U, Boissell JP, Kleinert H. Expressional control of the constitutive isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12: 773-90.
3. Cattell V. Nitric oxide glomerulonephritis. Semin Nephrol 1999; 19: 277-87.
4. Wanchu A, Khullar M, Bambery P, Sud A. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 1998; 28: 41-3.
5. Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999; 26: 318-24.
6. Yang CW, Yu CC, Ko YC, Huang CC. Aminoguanidine reduces glomerular inductible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice. Clin Exp Immunol 1998; 113: 258-64.
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
8. Weening JJ, D'Agatti VD, Schwartz MM, Seshan SV, Alpers C, Appel G, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-50.
9. Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med 1983; 75: 382-91.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
11. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem. 1993; 214: 11-6.
12. Smith R, Robinson N, McPeake J, Baylis S, Charles I, Heaton N, Moncada S, Williams R, Martin J. Induction and Role of NO synthase in hipotensive hepatic failure. Arterioscler Thromb Vasc Biol. 1997; 17: 3079-82.
13. Aoki E, Takeuchi IK. Immunohistochemical localization of arginine and citrulline in rat renal tissue. J Histochem Cytochem 1997; 45: 875-81
14. Furusu A, Miyasaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney International 1998; 53: 1760-68.
15. Wan JS, Tseng HH, Shih DF, Jou HS, Ger LP. Expression of inducible nitric oxide synthase in human lupus nephritis. Nephron 1997; 77: 404-11.
16. Herrera-Esparza R, Barbosa-Cisneros O, Villalobos-Hurtado R, Avalos-Diaz E. Renal Expression of IL-6 and TNFα genes in lupus nephritis. Lupus 1998; 7: 154-58.
17. Takeda Y, Takeno M, Iwasaki M, Kobayashi H, Kirino Y, Ueda A, et al. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol 2004; 138: 237-244.
18. Nozaki Y, Yamagata T, Yoo BS, Sugiyama M, Ikoma K, Kinoshita K, et al. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF1 mice. Clin Exp Immunol 2005; 139: 74-83.
19. Curtis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Ménszeth S, et al. Almost all about citrulline in mammals. Amino Acids 2005; 29: 177-207.
20. Keilhoff G, Reiser M, Stanarius A, Aoki E, Wolf G. Citrulline immunohistochemistry for demonstration of NOS activity in vivo and in vitro. Nitric Oxide 2000; 4: 343-353.
21. Keilhoff G, Wolf G. Citrulline immunohistochemistry may not necessarily identify nitric oxide synthase activity: the pitfall of peptidylarginine deiminase. Nitric Oxide 2003; 8: 31-38.